Publications by authors named "Espen A Haavardsholm"

Claim this Profile
A
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprint.
Georgios K Vasileiadis, Yuan Zhang, Marion Laudette, Tahzeeb Fatima, Anna-Karin Hultgård Ekwall, Espen A Haavardsholm

J Transl Autoimmun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-detected crystal depositions and clinical flares dissolve during successful urate-lowering therapy: 5-year follow-up results from the treat-to-target NOR-Gout study.
Hilde Berner Hammer, Lars Karoliussen, Lene Terslev, Espen A Haavardsholm, Till Uhlig

Ann Rheum Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Results of Tapering Tumor Necrosis Factor Inhibitor to Withdrawal Compared to Stable Tumor Necrosis Factor Inhibitor Among Patients With Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial.
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge C Olsen, Espen A Haavardsholm

Arthritis Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DNA methylation-based algorithm for diagnosing rheumatoid arthritis.
Espen Riskedal, Astanand Jugessur, Silje Watterdal Syversen, Cathrine Lund Hadley, Jennifer R Harris, Espen A Haavardsholm

Arthritis Res Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
Tahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, Araz Rawshani, Ronald van Vollenhoven, Espen A Haavardsholm

Arthritis Res Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prevalence of Behçet's disease in Oslo, Norway: a two-decade population-based analysis.
Jing Lisa Li Lorentsen, Cathrine Brunborg, Anders T Aasebø, Jørgen Valeur, Espen A Haavardsholm

Rheumatology (Oxford)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial.
Inger Jorid Berg, Eirik K Kristianslund, Anne Therese Tveter, Joseph Sexton, Gunnstein Bakland, Espen A Haavardsholm

Ann Rheum Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
Tahzeeb Fatima, Yuan Zhang, Georgios K Vasileiadis, Araz Rawshani, Ronald van Vollenhoven, Espen A Haavardsholm

Arthritis Res Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission in gout is possible: 5-year follow-up in the NOR-Gout study.
Till Uhlig, Johan Stjärne, Lars Fridtjof Karoliussen, Joe Sexton, Tron Eskild, Espen André Haavardsholm

Semin Arthritis Rheum· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study.
Till Uhlig, Lars F Karoliussen, Joe Sexton, Sella A Provan, Espen A Haavardsholm

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study.
Gaoyang Li, Shrikant S Kolan, Franco Grimolizzi, Joseph Sexton, Giulia Malachin, Espen A Haavardsholm

Front Med (Lausanne)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Baseline CXCR3Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis.
Julia M Scheffler, Christina Drevinge, Catharina Lindholm, Inger Gjertsson, Kristina Lend, Espen A Haavardsholm

ACR Open Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis.
Georgios K Vasileiadis, Yuan Zhang, Tahzeeb Fatima, Ronald van Vollenhoven, Jon Lampa, Espen A Haavardsholm

ACR Open Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.
Hilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, Kristin H Bjørlykke, Joseph Sexton, Espen A Haavardsholm

Lancet Reg Health Eur· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.
Bas Dijkshoorn, Romy Hansildaar, Daisy Vedder, Nida Soutari, Anna Rudin, Espen A Haavardsholm

RMD Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial.
Kristina Lend, Jon Lampa, Leonid Padyukov, Merete Lund Hetland, Marte Schrumpf Heiberg, Espen A Haavardsholm

Ann Rheum Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.
Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund, Ingrid Jyssum, Joseph Sexton, Espen Andre Haavardsholm

RMD Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.
Asia-Sophia Wolf, Kristin H Bjørlykke, Hilde S Ørbo, Sabin Bhandari, Guri Solum, Espen A Haavardsholm

EBioMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials.
Karen Holten, Nina Paulshus Sundlisæter, Joseph Sexton, Kaja E Kjørholt, Lena Bugge Nordberg, Espen A Haavardsholm

RMD Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation of the first international research network to foster high-quality clinical trials testing non-pharmacological interventions (TRACTION network).
Ricardo J O Ferreira, Adriana Henriques, Rikke H Moe, Cristiano Matos, Anne-Therese Tveter, Espen A Haavardsholm

BMJ Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbon-Footprint Analyses in RCTs - Toward Sustainable Clinical Practice.
Lena B Nordberg, Heiko Pohl, Espen A Haavardsholm, Siri Lillegraven, Michael Bretthauer

N Engl J Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial.
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge C Olsen, Espen A Haavardsholm

Lancet Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study.
Violetta Dubovyk, Georgios K Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Espen A Haavardsholm

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.
Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton, Ingrid Jyssum, Anne T Tveter, Espen A Haavardsholm

RMD Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Scraps of national clinical guidelines from the Directorate of Health].
Lise M Helsingen, Eline Aurvoll Langeland, Synne Eline Rotihaug Pisani, Per Olav Vandvik, Espen A Haavardsholm

Tidsskr Nor Laegeforen· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis